T he continued use of animal serum as an important component in biotechnology manufacturing processes has raised questions regarding both the reliability of geographic origin and possible adulteration of product. The International Serum Industry Association (ISIA) has implemented a traceability certification program designed to demonstrate traceability from slaughterhouse or abattoir to the end-user. This is based on an audit performed by an independent, approved third-party auditor according to an approved audit plan, using a detailed audit checklist. Recent advances have led to the development of a complementary testing program to determine geographic origin of material. The methodology described in this paper differentiates fetal bovine serum from newborn calf serum on the basis of biochemical composition.
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By Michelle Cheever, Alyssa Master, and Rosemary Versteegen disease, both human and veterinary. One of the most varied factors in culture systems is the growth medium, which provides the nutrients and/or the growth factors required for cell growth and product yield. Growth media are most often supplemented at concentrations of 5-20 % serum by volume. The choice of which serum is most appropriate for use in any application can be a difficult one, and the selection of the serum supplier can be important to ensure quality product is available. FBS provides the proper cell growth environment for many applications, but is not yet fully characterized. NBCS presents a less expensive alternative to FBS but is also appropriate for use in some applications. This difference in value, which is based on availability, could provide an incentive for misrepresentation. The ability to differentiate between these serum types would therefore be important, and would, among other aspects, help to ensure reproducibility of results. This capability has not been available in the past. ISIA has promulgated an industry-approved list of serum definitions.
ISIA Definitions of FBS and NBCS:
• Fetal Bovine Serum is obtained from the blood of fetuses of healthy, pre-partum bovine dams that have been deemed fit for human consumption through ante-and/or post-mortem veterinary inspection. It is collected in abattoirs inspected by the competent authority in the country of origin. There are no deletions or additions (including preservatives) allowed.
• Newborn Calf Serum is the liquid fraction of clotted blood derived from healthy, slaughtered bovine calves aged less than 20 days, deemed fit for human consumption through ante-and/or post-mortem inspection. It is collected in abattoirs inspected by the competent authority of the country of origin. There are no deletions or additions (including preservatives) allowed. One of the goals of this study was to determine a biochemical fingerprint that could be used to individually identify these two types of bovine serum. A major difference between FBS and NBCS is the levels of circulating antibodies. This is due to the fact that colostrum, the first feed from mother to calf, is rich in antibodies which are essential for the establishment of the immune system of the calf. It has long been known that higher levels of immunoglobulin (IgG) are found in NBCS.
[1]
It is also known in other species that the birthing process can result in increased levels of other marker molecules. One of the simplest methods for assessing animal health
Serum and its Role in Cell Culture
Despite significant efforts to avoid the use of animalsource products, serum and other animal-derived products continue to play critical roles as culture medium supplements in the biomedical and biopharmaceutical arenas. Animal blood is a by-product of the meat industry and, as such, is sourced from animals fit for human consumption. Bovine-sourced products are the most commonly used. Serum, plasma, and other animal-derived materials from a large variety of animal sources are also used by the biopharmaceutical industry in daily applications including:
• Biomedical research • Cell culture-based safety testing of pharmaceuticals and cosmetics • Cell culture-based production of human and veterinary vaccines as well as therapeutic proteins • Cell therapies
Serum Use
Serum has been used extensively as a growth medium supplement in cell culture for many years, and its use for this purpose has greatly contributed to the battle against www.bioprocessingjournal.com status is to run a general veterinary panel of tests on a serum sample. This panel will give an indication of the general health and function of various organs. A list of the tests usually performed is shown in Table 1 . Such a panel is of particular interest because it provides useful markers for distinguishing between FBS and NBCS.
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Methods
Biochemical Profile of FBS and NBCS
Each unique FBS or NBCS sample was the result of the standard, multi-animal pool manufacturing process. Where indicated, samples were either filtered, finished p r o d u c t o r u n f i l t e r e d , un pro cessed raw serum, as processing did not appear to affect the results obtained. Statistical analysis was performed using GraphPad I n St a t Ve r s i o n 3 .1 f o r Microsoft Windows. A P-value less than 0.05 was considered statistically significant.
Thirty-nine FBS samples and 32 NBCS sample were obtained from five ISIAcertified traceable suppliers. Of these, 55 samples were submitted to a third party to be aliquoted, blinded, and directly submitted to the testing facility while 
Group Measurements Function
Electrolyte, Fluid, pH Balance
Indicators of dehydration, electrolyte, and acid/base balance. They are the main intracellular ions, and are responsible for the maintenance of osmotic pressure.
Vitamins and Minerals
• Phosphorus • Iron Important for synthesis of hemoglobin and activation of numerous enzymes and hormones.
Renal and Pancreas Function, Injury
Abnormal values indicate skeletal muscle damage. Includes assessment of kidney function.
Critical role in the function of the cell membrane. Lipids are precursors to hormones and aid in the absorption of nutrients from food.
Enzymes and protein that indicate soft tissue, liver, and bile duct damage.
Used to identify serum protein disorders. Albumin provides 80 % of osmotic activity in plasma and serves as a transport protein in metabolic processes. Changes in alpha globulin indicate acute phase of inflammation. Beta fractions of globulin are part of complement, transferrin, c-reactive protein, and some immunoglobulin. IgG is a type of antibody that is produced by the immune system.
[5]
• Anion Gap • Chloride Table 2 .
In order to identify which of the biochemical properties of NBCS were distinct from FBS, a comparison of the difference in the mean value of the results was performed. To determine the increase or decrease in level of analytes, the mean value for NBCS was divided by the mean value for FBS for each analyte, and transformed data (logarithm to base 2) were plotted as shown in Figure 1 (previous page).
Analytes exhibiting a fold change ≥ 2 are indicated in blue. Differences to the right of zero and ≥ 2 indicate that the NBCS value was greater than that for FBS (i.e., GGT, IgG, total bilirubin, and globulin). Changes to the left of zero and ≤ 2 indicate that the NBCS result was less than that for FBS (i.e., triglyceride, creatinine, and iron). The fold difference was statistically significant for GGT at 121.3 and IgG at 83.9. The maximum GGT value of the sample population for FBS was 5 IU/L. In contrast, the minimum GGT value of the sample population for NBCS was 157 IU/L. GGT was the analyte with the highest difference seen and became the focus of further experiments.
High GGT and IgG were found to have statistically significant associations with NBCS. A GGT of > 100 was associated with NBCS while that for FBS was < 10. FBS is characterized as having a significantly lower IgG when compared to NBCS but showed a wider range of values when compared to GGT ranges. Although a www.bioprocessingjournal.com A Method for Differentiating Fetal Bovine Serum from Newborn Calf Serum specification level for IgG has not yet been set by ISIA, it is more commonly reported on manufacturer's FBS certificates of analysis (COA). This analysis shows that in instances where IgG is > 320 μg/mL (+ 1 SD from the mean), then an evaluation of GGT would be a determining factor for characterizing serum.
Variation
Five FBS and three NBCS samples of US origin were submitted to nine separate facilities for GGT analysis. Samples were transported on dry ice and stored frozen until the initial analysis was performed. Samples were then refrigerated until a re-evaluation could be performed 24 hours later.
In Figure 2 , N was adjusted for instances where analysis was not performed 24 hours after initial evaluation. GGT results obtained by the different analyzers are summarized in Figure 2A for FBS and Figure 2B for NBCS. A statistically significant difference was observed for FBS using the Siemens Dimension Xpand when compared to the Beckman and Roche analyzers. Maximum FBS GGT for the Beckman and Roche analyzers was 7 IU/L. No statistical significance with NBCS was observed for all the analyzers. Analysis was performed using Kruskal-Wallis test (nonparametric one-way analysis of variance [ANOVA]). There was a statistically higher amount of FBS GGT, as determined 
Variation in Results
FBS GGT data obtained using the Roche cobas c 501 analyzer are summarized in Table 3 . The data set includes five samples analyzed at two locations, CSU and UC Davis, over a period of 24 hours. There was no significant difference in the mean results for GGT tested at these diagnostic facilities (P > 0.05) when analyzed using nonparametric ANOVA and Dunn's multiple comparison. No significant difference was observed in GGT (P > 0.999, unpaired t -test) when samples were re-analyzed within a 24-hour period. There was no significant variation in GGT results based on testing facility, time of analysis, or the Beckman and Roche analyzers.
The Siemens Dimension Xpand analyzer gave statistically significant differences in measurements of GGT in FBS, but not for NBCS. Variations between Beckman and Roche analyzers were not statistically significant for FBS or NBCS. GGT values were reproducible regardless of the testing facility and not susceptible to variation, suggesting that this might be the most useful marker for differentiating NBCS from FBS. It should be stressed that if FBS GGT is analyzed using the Siemens Dimension Xpand, values over 10 IU/L will be reported.
Detecting NBCS in FBS
Three NBCS samples were diluted into FBS from 5-20 % (in increments of 5 %) by volume. Diluted samples were submitted to the CSU diagnostic facility for GGT determination by the cobas c 501 analyzer. Figure 3A shows the results of the mixing experiments. The average GGT level detected was plotted against the percentage of NBCS dilution. This suggested a strong linear relationship between the percent dilution of NBCS and the corresponding GGT measurement (R 2 = 0.9994). In order to further analyze statistical variance, the sum of the squares of the deviations from the mean (SDM) was calculated to be 9.113, indicating little variance. The predicted GGT value of the various levels of mixtures was determined Table 2 ). The slope was 4.342, the Y intercept was 2.145, and there was an R 2 value of 0.9993. The percent of NBCS diluted in FBS can be calculated using reported values of GGT, and the slope and Y intercept from the average sample results. For example, a GGT result of 50 IU/L would intercept this standard curve at 11.02 %. A reasonable assumption would therefore seem to be that a GGT result of 50 IU/L could contain 8-20 % NBCS (+/-1 SD). In Figure 3B (previous page), the maximum observed value for GGT of 7 IU/L is shown for reference and intercepts at 1.15 %.
In this study, we categorized FBS as having GGT values of < 10 IU/L. Reported GGT values over 10 IU/L in FBS would strongly suggest that the material is not entirely derived from fetal origin.
Conclusions
For many years, low levels of IgG were thought to be a suitable marker for FBS. [3, 6] This has been questionable, based on the wide range of levels observed, and also the potential for removal of IgG from serum using protein A chromatography. In fact, commercially available ultra-low IgG FBS can be obtained from several suppliers. Earlier work [3, 4] indicated the presence of GGT in bovine serum. GGT was a potential indicator for passive transfer of immunity and might be an indicator of neonatal vs. fetal origin. The work discussed here strongly indicates that GGT can be used to distinguish NBCS from FBS. The presence of NBCS in FBS may be detected using this method, based on our analysis showing higher than expected GGT levels. Therefore, the method may be useful for detecting the adulteration of FBS by dilution in NBCS. ISIA will be working in the very near future to recommend specifications for IgG and GGT levels for FBS based on the results of this analytical study.
